Legend Biotech (LEGN) Other Gross PP&E Adjustments (2019 - 2025)
Legend Biotech (LEGN) posted Other Gross PP&E Adjustments of -$285.2 million for Q4 2025, down 100.37% on a QoQ basis from -$142.3 million in Q3 2025, and down 179.88% year-over-year from $357.0 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Other Gross PP&E Adjustments data on file, last reported at -$285.2 million in Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments fell 179.88% year-over-year to -$285.2 million; the TTM figure through Dec 2025 stood at -$285.2 million (down 179.88% YoY), while the FY2025 annual figure was -$285.2 million, down 179.88% from the prior year.
- Other Gross PP&E Adjustments slipped to -$285.2 million in Q4 2025, from -$142.3 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$7547.0 in Q1 2021 and bottomed at -$285.2 million in Q4 2025.
- A 5-year average of -$84.5 million and a median of -$80.3 million in 2023 frame the typical range for Other Gross PP&E Adjustments.
- Annual changes were most pronounced in 2021 — Other Gross PP&E Adjustments increased 8.08% — and 2022, when it tumbled 526877.61%.
- Year by year, Other Gross PP&E Adjustments stood at -$38.3 million in 2021, then plunged by 45.21% to -$55.6 million in 2022, then slumped by 44.81% to -$80.5 million in 2023, then retreated by 26.58% to -$101.9 million in 2024, then slumped by 179.88% to -$285.2 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$285.2 million (Q4 2025), -$142.3 million (Q3 2025), and -$127.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -75.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -285.20 Mn |
| Dec 31, 2025 | -285.20 Mn |
| Sep 30, 2025 | -142.34 Mn |
| Sep 30, 2025 | -142.34 Mn |
| Jun 30, 2025 | -127.22 Mn |
| Jun 30, 2025 | -127.22 Mn |
| Mar 31, 2025 | -107.22 Mn |
| Mar 31, 2025 | -107.22 Mn |
| Dec 31, 2024 | -101.90 Mn |
| Dec 31, 2024 | -101.90 Mn |
| Sep 30, 2024 | -99.45 Mn |
| Sep 30, 2024 | -99.45 Mn |
| Jun 30, 2024 | -114.72 Mn |
| Jun 30, 2024 | -114.72 Mn |
| Mar 31, 2024 | -80.18 Mn |
| Mar 31, 2024 | -80.18 Mn |
| Dec 31, 2023 | -80.50 Mn |
| Dec 31, 2023 | -80.50 Mn |
| Sep 30, 2023 | -74.81 Mn |
| Sep 30, 2023 | -74.81 Mn |
| Jun 30, 2023 | -78.50 Mn |
| Jun 30, 2023 | -78.50 Mn |
| Mar 31, 2023 | -80.46 Mn |
| Mar 31, 2023 | -80.46 Mn |
| Dec 31, 2022 | -55.59 Mn |
| Dec 31, 2022 | -55.59 Mn |
| Mar 31, 2022 | -39.77 Mn |
| Mar 31, 2022 | -39.77 Mn |
| Dec 31, 2021 | -38.28 Mn |
| Dec 31, 2021 | -38.28 Mn |
| Sep 30, 2021 | -7.56 Mn |
| Sep 30, 2021 | -7.56 Mn |
| Jun 30, 2021 | -7.31 Mn |
| Jun 30, 2021 | -7.31 Mn |
| Mar 31, 2021 | -7,547.00 |
| Mar 31, 2021 | -7,547.00 |
| Dec 31, 2020 | -41.65 Mn |
| Dec 31, 2020 | -41.65 Mn |
| Sep 30, 2020 | -8,077.00 |
| Sep 30, 2020 | -8,077.00 |
| Jun 30, 2020 | -7,786.00 |
| Jun 30, 2020 | -7,786.00 |
| Dec 31, 2019 | -2.85 Mn |
| Dec 31, 2019 | -2.85 Mn |